Evicenter
P&T meetings

Emiltatug ledadotin (Emi-Le)

Adenoid cystic carcinoma with solid histology or high-grade transformation

Also known as XMT-1660
Manufacturer
Servier
Regulatory submission
Not announced
Launch
Not announced
Last updated
125 sources

Product information and disease descriptionPlace of product in therapyDisease description

Long-term morbidity

6 evidence topics · 6 sources

Summary: long-term morbidity

Long-term morbidity in ACC results from the tumor (perineural spread with facial pain, paralysis, and cranial neuropathies), from repeated local therapy for recurrences, and from the need for lifelong follow-up because distant metastases can occur more than 20 years after diagnosis. In a multinational study of 60 survivors of salivary gland cancer (all histologies) more than 5 years after diagnosis, the most frequently reported long-term problem was dry mouth (21 participants, about one third), and the most frequent grade 2 to 3 clinician-assessed toxicities were hearing impairment (13), soft tissue fibrosis (9), dry mouth (8), and cranial neuropathies (8). No study reporting long-term morbidity specifically for solid or high-grade ACC was identified.